|1.||Trudel, Marie: 1 article (01/2010)|
|2.||Otterbein, Leo E: 1 article (01/2010)|
|3.||Vandorpe, David H: 1 article (01/2010)|
|4.||Xu, Chang: 1 article (01/2010)|
|5.||Brugnara, Carlo: 1 article (01/2010)|
|6.||Sachs, Frederick: 1 article (01/2010)|
|7.||Gottlieb, Philip A: 1 article (01/2010)|
|8.||Shmukler, Boris E: 1 article (01/2010)|
|9.||Alper, Seth L: 1 article (01/2010)|
|10.||Chen, Xiaoje: 1 article (05/2009)|
|1.||Cardiac Arrhythmias (Arrythmia)
01/01/2006 - "While all three can prevent mechanically-induced cardiac arrhythmias in experimental situations, only GsMTx-4 seems to have the potential as a novel therapeutic agent for the targeting of arrhythmias provoked by MSCs."
08/15/2005 - "SM sheets, in which some of the myotubes displayed automaticity, caused fibrillation-like contraction in the co-cultured CM sheets, and this arrhythmia was specifically blocked by the stretch-activated channel blocker GsMTx-4. "
|2.||Neuralgia (Stump Neuralgia)
05/13/2009 - "Intradermal injection of GsMTx-4 in the rat hindpaw reversed the mechanical hyperalgesia induced by intradermal injection of inflammatory mediators. "
05/13/2009 - "Furthermore, GsMTx-4 reduced hyperalgesia to both mechanical and hypotonic stimuli in different models of inflammatory and neuropathic pain, although it had no effect on baseline mechanical nociceptive thresholds. "
|4.||Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
|2.||Streptomycin (Streptomycin Sulfate)